Product Information
DICLEGIS DR 10-10 MG TABLET is a brand product labeled by Duchesnay USA, Inc., priced at $1.6714 per EA under NDC 55494010010. Its NADAC has been published 665 times since Nov 28, 2013.
FDA first approved this application on Apr 8, 2013. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the doxylamine succinate and pyridoxine hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
10; 10 mg/1; mg/1
Manufacturer
Duchesnay USA, Inc.NDC
55494010010
Classification
Brand
Dosage Form
TABLET, DELAYED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
DOXYLAMINE SUCCINATE; PYRIDOXINE HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA021876FDA Approved
4/8/2013
TE Code
AB
On Market Since
5/15/2013
Pharmacological Classes
Price Statistics
The NADAC for DICLEGIS DR 10-10 MG TABLET has been published 665 times since Nov 28, 2013, and over the history we have for it it has declined 63.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.6714 per EA |
|---|---|
| All-time high | $6.5992 (Mar 11, 2020) |
| All-time low | $1.6714 (Aug 19, 2026) |
| 52-week high | $1.9957 |
| 52-week low | $1.6714 |
| Median price | $5.2322 |
| Average price | $4.9905 |
| Largest weekly change | -40.1% (Apr 10, 2024) |
| Weeks tracked | 665 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 24% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of DICLEGIS DR 10-10 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for DICLEGIS DR 10-10 MG TABLET, manufactured by Duchesnay USA, Inc., is $1.6714 per EA (NDC 55494010010), effective Aug 19, 2026.
How has the price of DICLEGIS DR 10-10 MG TABLET changed over time?
Over the history we have for it, the NADAC for DICLEGIS DR 10-10 MG TABLET has declined 63.4%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for DICLEGIS DR 10-10 MG TABLET?
Since Nov 28, 2013, the NADAC for DICLEGIS DR 10-10 MG TABLET has ranged from a low of $1.6714 (Aug 19, 2026) to a high of $6.5992 (Mar 11, 2020), with a median of $5.2322 per EA.
Are there cheaper alternatives to DICLEGIS DR 10-10 MG TABLET?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DOXYLAMINE-PYRIDOXINE 10-10 MG, is $1.2627 per EA — about 24% below DICLEGIS DR 10-10 MG TABLET.
Who manufactures DICLEGIS DR 10-10 MG TABLET?
DICLEGIS DR 10-10 MG TABLET (NDC 55494010010) is labeled by Duchesnay USA, Inc., and CMS classifies it as a brand product.